<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Gen Hosp Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Gen Hosp Psychiatry</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>General hospital psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0163-8343</issn><issn pub-type="epub">1873-7714</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11634658</article-id><article-id pub-id-type="pmcid-ver">PMC11634658.1</article-id><article-id pub-id-type="pmcaid">11634658</article-id><article-id pub-id-type="pmcaiid">11634658</article-id><article-id pub-id-type="manuscript-id">NIHMS2024695</article-id><article-id pub-id-type="pmid">39378616</article-id><article-id pub-id-type="doi">10.1016/j.genhosppsych.2024.09.013</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2024695</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2024695</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Opioid-Related Emergency Admissions in People with Opioid Dependence/Use Disorder With and Without Sickle Cell Disease: An Analysis of Multi-State Insurance Claims</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="SA">Shiyuan A</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brown</surname><given-names initials="TR">Tashalee R</given-names></name><degrees>MD PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>King</surname><given-names initials="AA">Allison A</given-names></name><degrees>MD MPH PhD</degrees><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="LA">Lewei Allison</given-names></name><degrees>MD MS</degrees><xref rid="A6" ref-type="aff">6</xref><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rehman</surname><given-names initials="SS">Sana S</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grucza</surname><given-names initials="RA">Richard A</given-names></name><degrees>PhD</degrees><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="KY">Kevin Y</given-names></name><degrees>MD MPH</degrees><xref rid="A9" ref-type="aff">9</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Hospital Medicine, Department of Medicine, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO 63110</aff><aff id="A2"><label>2</label>Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, 760 Westwood Plaza, Los Angeles, CA 90024</aff><aff id="A3"><label>3</label>Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, 760 Westwood Plaza, Los Angeles, CA 90024</aff><aff id="A4"><label>4</label>Division of Hematology and Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 660 S. Euclid Ave, St. Louis, MO 63110</aff><aff id="A5"><label>5</label>Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA, 660 S. Euclid Ave, St. Louis, MO 63110</aff><aff id="A6"><label>6</label>Department of Psychiatry, University of Michigan Medical School, 4250 Plymouth Rd, Ann Arbor, MI, 48109</aff><aff id="A7"><label>7</label>Center for Clinical Management Research (CCMR), Veteran Affairs Ann Arbor Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105</aff><aff id="A8"><label>8</label>Departments of Family and Community Medicine and Health and Outcomes Research, St. Louis University, 1008 S. Spring Avenue, St. Louis, MO 63110</aff><aff id="A9"><label>9</label>Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA, 660 S. Euclid Ave, St. Louis, MO 63110</aff><author-notes><corresp id="CR1">CORRESPONDING AUTHOR: Kevin Y Xu MD MPH, Assistant Professor of Psychiatry, Department of Psychiatry, Washington University, Renard 3007, 4940 Children&#8217;s Place | Saint Louis, MO 63110, Fax: 314-970-9094, <email>xukeviny@wustl.edu</email></corresp></author-notes><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>24</day><month>9</month><year>2024</year></pub-date><volume>91</volume><issue-id pub-id-type="pmc-issue-id">476885</issue-id><fpage>83</fpage><lpage>88</lpage><pub-history><event event-type="nihms-submitted"><date><day>23</day><month>10</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>12</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>12</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-17 14:25:13.860"><day>17</day><month>12</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2024695.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P1">We estimated rates of opioid-related admissions in people with sickle cell disease (SCD) diagnosed with opioid-related disorders.</p></sec><sec id="S2"><title>Method:</title><p id="P2">This retrospective cohort study analyzed ten years (1/2006&#8211;12/2016) of multi-state claims data from 191,638 people receiving treatment for opioid-related disorders in the U.S. We used multivariable cox regression to estimate the association between admissions for opioid-related adverse events (i.e., overdose) after initiating treatment and SCD status (SCD[n=320] vs no SCD[n=191,318]) among people with opioid-related disorders, controlling for sociodemographic variables and comorbidities. In secondary analyses, we excluded events occurring simultaneously as vaso-occlusive crises (VOCs) and computed rates of admissions for non-opioid substance-related events (i.e., alcohol, cannabis, stimulants).</p></sec><sec id="S3"><title>Results:</title><p id="P3">Whereas 287(90%) of the SCD cohort had &gt;1 all-cause admission, of which 199 were for VOCs, only 78(20%) experienced an opioid-related adverse event. The SCD cohort experienced higher rates of opioid-related admissions than the non-SCD cohort (aHR=1.82[95% CI=1.51&#8211;2.19), a finding that remained robust even after excluding events that occurred at the same time as a VOC. However, SCD diagnoses were not associated with increased risk of admissions for non-opioid substance-related events.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Most individuals diagnosed in the chart with opioid-related disorders with SCD did not experience opioid-related admissions during enrollment. Even though clinicians may perceive people with SCD as being at elevated risk for substance use disorders, opioid-related admissions made up only a small fraction of all-cause admissions in the SCD cohort, in contrast to VOCs that comprised the majority of admissions. While opioid-related admission rates were modestly higher among those with SCD than among peers without SCD, SCD was not a risk factor non-opioid substance-related admissions.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>